Kicort 12 Tablet contains Deflazacort 12mg, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, allergic reactions, and certain dermatological disorders. Deflazacort works by modulating the immune response and reducing the production of inflammatory mediators, thereby alleviating symptoms like swelling, redness, and pain. The drug is also used in the treatment of certain muscular dystrophies to improve muscle strength and function. Kicort 12 should be administered under medical supervision, with dosage tailored to the specific condition and patient response. It is important to monitor for potential side effects, including immunosuppression, hyperglycemia, osteoporosis, and adrenal suppression, especially during long-term therapy. Abrupt discontinuation is not recommended due to the risk of adrenal insufficiency; gradual tapering is advised. Patients should inform their healthcare provider of any pre-existing conditions such as infections, diabetes, or hypertension before initiating therapy. Kicort 12 Tablet offers a valuable therapeutic option in the management of inflammatory and autoimmune diseases when used appropriately and monitored closely.